Myosin-9 (MYH9 or DFNA17) Antibody

Scientific Overview

This antibody supports experimental designs that investigate Myosin-9 (MYH9) with interpretable controls and clear contrasts. Myosin-9 is a scaffold that can coordinate signaling with cytoskeletal remodeling. Plan positive and negative controls that match your model system, including perturbations expected to shift the target.

Following Myosin-9 across perturbations can help separate expression effects from compartment shifts.

Research Relevance

Because cytoskeletal proteins can be abundant, interpretation benefits from attention to dynamic range and saturation. Time course design can be decisive when regulation is transient or compartment dependent.

Since many cellular processes are coupled, measured differences can reflect both direct regulation and indirect effects from broader state changes. Kidney disease modeling efforts may include this target when exploring podocyte stress responses and structural change.

When building a narrative around the target, it helps to track:

• association with junctional complexes or focal adhesions
• stress-fiber versus cortical distribution patterns
• remodeling after perturbation of polymerization or contractility

Application-Specific Context

When assay conditions are still being tuned, a regular-format antibody supports stepwise adjustment of buffers and incubation steps. Think about how preparation affects epitope accessibility, and interpret patterns alongside morphology and compartment markers as needed. Align controls to the expected direction of change to support confident interpretation.

To support downstream analysis, record key context variables (culture timing, stimulation window, and extraction approach) so Myosin-9 patterns can be compared across experiments without guesswork.

The regular format format fits designs where Myosin-9 (MYH9) is evaluated with deliberate controls and careful comparisons.